Exploring the Diagnostic Potential of Core Targets of 6PPD and Its Metabolite 6PPD‐Q in Cardiovascular Diseases: An Integrated Analysis Based on Network Toxicology, Molecular Docking, and In Vitro Validation
Authors:
- 12 August 2025
- journal article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (1) , 281-297
Abstract
6PPD ( N ‐(1,3‐dimethylbutyl)‐ N ′‐phenyl‐ p ‐phenylenediamine) and its oxidized form, 6PPD‐Q (2‐((4‐methylpentan‐2‐yl)amino)‐5‐(phenylamino)cyclohexa‐2,5‐diene‐1,4‐dione), are commonly used in rubber‐based materials and have been increasingly found in the environment. Recent studies suggest that these compounds may be toxic to the cardiovascular system, but the exact molecular mechanisms are not well understood. This study used a combination of network toxicology, molecular docking, and bioinformatics to investigate how 6PPD and 6PPD‐Q affect the heart, particularly in relation to atherosclerosis, acute myocardial infarction, and heart failure. By screening multiple databases and analyzing Gene Expression Omnibus (GEO) transcriptome data, we identified key targets that are involved in these diseases. We built PPI networks and performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses to explore the related pathways. Additionally, we validated four core targets—nuclear receptor subfamily 4 group A member 3 (NR4A3), sphingosine‐1‐phosphate receptor 3 (S1PR3), nicotinamide phosphoribosyltransferase (NAMPT), and formyl peptide receptor 1 (FPR1)—that showed high diagnostic value in all three diseases using receiver operating characteristic (ROC) analysis. Molecular docking revealed that both 6PPD and 6PPD‐Q strongly bind to these targets. Further in vitro experiments revealed that 6PPD and 6PPD‐Q induce damage in H9c2 cells. The mechanism may be associated with these four targets. This study sheds light on how these environmental pollutants harm the cardiovascular system and demonstrates the value of combining network toxicology with omics and structural biology in risk assessment and therapeutic development.Keywords
This publication has 47 references indexed in Scilit:
- NR4A3 prevents diabetes induced atrial cardiomyopathy by maintaining mitochondrial energy metabolism and reducing oxidative stressEBioMedicine, 2024
- A Network Toxicology Approach for Mechanistic Modelling of Nanomaterial Hazard and Adverse OutcomesAdvanced Science, 2024
- The potential impact of 6PPD and its oxidation product 6PPD-quinone on human health: A case study on their interaction with human serum albuminChemosphere, 2024
- Salvianolic acid A alleviates heart failure with preserved ejection fraction via regulating TLR/Myd88/TRAF/NF-κB and p38MAPK/CREB signaling pathwaysBiomedicine & Pharmacotherapy, 2023
- CDR1as promotes arrhythmias in myocardial infarction via targeting the NAMPT-NAD+ pathwayBiomedicine & Pharmacotherapy, 2023
- Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An In silico ApproachChemistrySelect, 2023
- Silybin phytosome attenuates cerebral ischemia‐reperfusion injury in rats by suppressing oxidative stress and reducing inflammatory response: In vivo and in silico approachesJournal of Biochemical and Molecular Toxicology, 2022
- The protective role of NR4A3 in acute myocardial infarction by suppressing inflammatory responses via JAK2-STAT3/NF-κB pathwayBiochemical and Biophysical Research Communications, 2019
- Identification of New Potent Human Uncoupling Protein 1 (UCP1) Agonists Using Virtual Screening and in vitro ApproachesMolecular Informatics, 2019
- Deficiency of the NR4A Orphan Nuclear Receptor NOR1 in Hematopoietic Stem Cells Accelerates AtherosclerosisStem Cells, 2014